Navigation Links
$1 million for smart energy solutions
Date:5/3/2013

Montreal, May 3, 2013 In a climate as prone to extremes as Canada's, buildings are often inefficient to heat, light and cool. Fortunately, innovative solutions are being explored through the NSERC Smart Net-zero Energy Buildings Strategic Network (SNEBRN), a nationwide university initiative headquartered at Concordia, which has just received $1 million in new funding from Natural Resources Canada (NRCan).

"Through the ecoENERGY Innovation Initiative, our Government is investing in innovative clean energy technologies that create jobs, generate new economic opportunities and protect the environment," said the Honourable Joe Oliver, Canada's Minister of Natural Resources. "This program demonstrates our tangible support for energy projects that drive energy innovation."

The funding will help the network conduct further research and testing of progressive technologies, and to explore how to more efficiently integrate these technologies into buildings. The research has two principle aims: "proof of concept" studies that demonstrate the effectiveness of new technologies, and validation studies that show how these technologies can be integrated in the built environment.

"Concordia is ideally positioned to play a strong role in the nationwide research effort to invent and refine the smart energy solutions of tomorrow," says Alan Shepard, President of Concordia University. "This new grant from NRCan builds on the solar energy expertise established through the Solar Buildings Research Network, which was headquartered at Concordia from 2005-2010."

Created in December 2011 with major funding from the Natural Sciences and Research Council of Canada (NSERC), SNEBRN brings together 29 Canadian researchers from 15 universities to develop the smart net-zero energy homes and commercial buildings of the future. The goal is to invent and implement technologies that make it possible for buildings to generate as much energy as they consume (ne
'/>"/>

Contact: Clea Desjardins
clea.desjardins@concordia.ca
514-848-242-45068
Concordia University
Source:Eurekalert

Page: 1 2

Related biology news :

1. UnitedHealth Group grants more than $1 million for the heart of New Ulm project
2. Scientists awarded $5.5 million for wheat, rice blast research
3. 100+ million mapped (and growing) records of nearly every living US species
4. U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care
5. $12 million for a center for research on aphasia
6. Pig wasting syndrome costing farmers millions
7. Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants
8. John Moores gives $2 million to Scripps Research to develop river blindness field test
9. Forsyth Institute receives $4.1 million grant for new center
10. UF researcher describes new 5-million-year-old saber-toothed cat from Florida
11. Spiral Genetics Closes $3 Million in Funding Led by DFJ and Announces Partnership with Omicia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... Oct. 15, 2014   Neurotechnology , a ... the availability of the VeriLook Surveillance 3.0 ... provides real-time biometric face identification using live video ... cameras. The new version not only identifies faces ... from objects while they are moving through the ...
(Date:10/14/2014)... house fly genome for the first time, revealing robust ... that thrives in pathogen-rich dung piles and garbage heaps. ... Genome Biology , will increase understanding of house ... adapt to resist insecticides, which could lead to novel ... and transmit more than 100 human and animal diseases, ...
(Date:10/14/2014)... LA JOLLA, CA – October 14, 2014 – Scientists ... $6.6 million from the National Institutes of Health (NIH) ... most prevalent virus-induced hemorrhagic fever disease in Africa. The ... disease and why some patients die, while others survive ... researchers to understand the basic mechanism of how Lassa ...
Breaking Biology News(10 mins):VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3House fly genome reveals expanded immune system 2Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2
... anachronism? Or is it a vital part of a ... 2.4 billion more people by the year 2050, the drive ... , But there,s an important downside to this trend, argues ... Montreal, in a paper to be presented Saturday, Feb. 15, ...
... Calif.) When mothers feed their newborns formula in the ... in the second month of life and more likely to ... longer, UC Davis researchers have found. "We are ... hospital can cause problems by reducing how much women breastfeed ...
... Rochelle, NY, February 13, 2014Food spoiling and poisoning caused ... economic problems. The broad scope of antimicrobial approaches to ... and beverages, including a variety of natural and artificial ... in Industrial Biotechnology , a peer-reviewed journal from ...
Cached Biology News:Making biodiverse agriculture part of a food-secure future 2Making biodiverse agriculture part of a food-secure future 3In-hospital formula use deters breastfeeding 2In-hospital formula use deters breastfeeding 3
(Date:10/22/2014)... and BOSTON , Oct. ... ), a leading global specialty pharmaceutical company, and Rhythm, ... granted an exclusive option to acquire Rhythm,s wholly owned ... a peptide ghrelin agonist, for the treatment of diabetic ... Rhythm has completed a successful Phase 2 trial of ...
(Date:10/22/2014)... Involution Studios , a healthcare software ... infographic, Understanding Ebola . The goal of ... to follow informative tool for anyone wanting to know ... prevention. , "As the news has spread in all ... represents not only a healthcare crisis with global impact, ...
(Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2
... Longer-term Phase 2 Switching Study, CRANBURY, ... company developing small-molecule, orally administered,pharmacological chaperones for ... that the Company will present positive results ... (isofagomine tartrate) for Gaucher disease,at the American ...
... on the strangeness of the nanoworld, researchers at the ... University of Maryland-College Park have discovered that materials such ... behave as ductile as gold at the nanoscale. Their ... NIST scientists Pradeep Namboodiri and Doo-In Kim and colleagues ...
... Calif., March 12 ,Exelixis, Inc. (Nasdaq: EXEL ) ... executive officer of Exelixis, will present at the,Cowen and ... / 1:00 p.m.,PT on Monday, March 17, 2008. Dr. ... corporate strategy., The presentation will be webcast and ...
Cached Biology Technology:Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 2Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 3Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 4Nanomaterials show unexpected strength under stress 2
... Ambion's ActivePro In ... from an E.coli lysate, ... protein as well as ... activity than competing kits. ...
... Mouse Serum • Mouse serum is collected off ... and 8-12 weeks of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD ...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
One-step, microplate or cuvet, colorimetric, linear detection range 0.6 mM to 100 mM. Procedure: 2 min....
Biology Products: